ArticleProceedings of the National Academy of Sciences of the United States of America2022

PROX1 transcription factor controls rhabdomyosarcoma growth, stemness, myogenic properties and therapeutic targets.

Nebeyu Yosef Gizaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.